An opportunity to determine optimal treatment of pT3 prostate cancer: the window may be closing.
Thompson
I M
IM
Urology Service, Brooke Army Medical Center, San Antonio, Texas.
Paradelo
J C
JC
Crawford
E D
ED
Coltman
C A
CA
Blumenstein
B
B
D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D018714:Radiotherapy, Adjuvant; D015996:Survival Rate